WDTC1 and cancer: To investigate the possible implication of ADP-ribosylation (both MAR- and PARylation) in cancer we performed a comprehensive study by immunohistochemically staining TMAs with a recently developed anti-ADP-ribose (ADPr) antibody that recognizes both MAR- and PARylation [31, 32].